Generic Paxil Approved By FDA; Apotex Faces Tricky Launch Decision
Executive Summary
Apotex faces an interesting calculation in determining whether and when to launch its generic version of Paxil
You may also be interested in...
Apotex Challenges FDA “Shared” Generic Exclusivity Policy In Paxil Suit
TorPharm is challenging FDA's policy of awarding "shared" 180-day marketing exclusivity to multiple generic companies
Apotex Challenges FDA “Shared” Generic Exclusivity Policy In Paxil Suit
TorPharm is challenging FDA's policy of awarding "shared" 180-day marketing exclusivity to multiple generic companies
Apotex Generic Paxil Priced At 7% Discount Following “At Risk” Launch
Apotex is relying on a district court ruling of noninfringement in launching the first generic of GlaxoSmithKline's antidepressant Paxil (paroxetine)